Download App
Direct answer: this calendar reproduces selected reference steps; it does not personalize treatment.

Use it to view dates implied by a selected label or investigational trial sequence, then verify every step against current prescribing information and qualified clinician instructions.

Current Dose
Protocol Week
Next Escalation
Reach Maintenance
Escalation progress 0%

Track doses & vials in Halflife

The iOS app records injections, schedules, and clearly labeled model estimates, with optional reminders. On-device, no account required.

Download on App Store

Related Tools

Generated Reference Dates

The table below places the selected reference steps onto calendar dates. Status labels describe the selected calendar only; they are not treatment instructions.

Generated dates for the selected label or investigational trial reference
StepReference dateDisplayed amountCalendar status

How to Use This Label-Schedule Reference

Select a product and start date to place its documented label steps, or an explicitly labeled investigational trial design, onto a calendar. The generated dates are a reference view only. They do not establish what dose, target, pace, or product is appropriate for an individual.

  1. 1Select the exact product context. Wegovy, Ozempic, Mounjaro, and Zepbound have different indications and labeling.
  2. 2Enter a reference start date to calculate calendar dates from the documented minimum step intervals.
  3. 3Compare every generated date with current prescribing instructions. A prescriber may delay, stop, or change a schedule.

Approved Labels vs Investigational Protocols

Important distinction: tirzepatide and semaglutide product schedules must be interpreted from their current formulation- and indication-specific labels. Retatrutide remains investigational; any displayed sequence reflects a trial design, not an approved dosing schedule.

A calendar cannot determine tolerability, contraindications, interactions, clinical response, or whether a dose increase should occur. Do not use generated dates to self-escalate, skip a step, or substitute one product's schedule for another.

Why a Generated Schedule May Differ From Care

  • The current label, indication, formulation, or prescribed target may differ from the selected reference.
  • A qualified clinician may hold or change a dose based on tolerability, response, access, or other clinical factors.
  • Missed-dose instructions are product-specific and are not replaced by this calendar.
  • Investigational trial schedules do not establish approved or generally appropriate use.

Frequently Asked Questions

Is this a personalized titration plan?

No. It is a calendar rendering of selected reference steps and cannot determine an appropriate individual plan.

Can I use the calendar to skip or accelerate a step?

No. Follow the current product label and qualified prescriber instructions.

Is the retatrutide schedule FDA approved?

No. Retatrutide is investigational, and the displayed sequence is explicitly a trial-design reference.

Calendar reference only. It does not provide a diagnosis, personalized treatment plan, dose recommendation, or instruction to start, stop, hold, or change a medicine. Methodology · Terms